23andMe Lays Off 40% of Its Workforce as Company Spirals
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire workforce, according to a press release Monday. The move is part of a restructuring that will see the company also halt the development of its therapeutics division which had been working on various potential medical treatments.
In the wake of a big data breach and a sizable new round of layoffs, concerns about the 23andMe's handling of sensitive ...
More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...
23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The ...
Me Holding Co.’s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, shedding ...
Genetics-testing company 23andMe has warned there is “substantial doubt” over its continued survival unless it raises new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback